Clinical Trial Update: Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and immunogenicity when co-administering HPV vaccine with another vaccine in healthy female subjects has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections

Drugs mentioned

• Human papillomavirus vaccine (human papillomavirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-01-06